| 1. | EXECUTIVE SUMMARY |
| 1.1. | Glossary of terms |
| 1.2. | Colors of biotechnology |
| 1.3. | What is white biotechnology? |
| 1.4. | White Biotechnology 2024-2034: scope |
| 1.5. | Trends and drivers in white biotechnology |
| 1.6. | Synthetic biology as applied to white biotechnology |
| 1.7. | Technology trends in white biotechnology |
| 1.8. | Overview of alternative feedstocks for white biotechnology |
| 1.9. | Major market challenges for white biotechnology |
| 1.10. | Technical challenges facing white biotechnology |
| 1.11. | Products derived from white biotechnology: overview |
| 1.12. | Molecules that can be produced through industrial biomanufacturing |
| 1.13. | Molecules that can be produced through industrial biomanufacturing |
| 1.14. | Company landscape in white biotechnology |
| 1.15. | Company landscape in white biotechnology |
| 1.16. | Next-generation fuels through white biotechnology |
| 1.17. | Bioplastics through white biotechnology |
| 1.18. | Navigating biobased polymers from monosaccharides |
| 1.19. | Common bioplastics and polymer precursors synthesized via white biotechnology |
| 1.20. | Status of molecules produced through white biotechnology |
| 1.21. | White biotechnology market share by molecule 2024-2034 |
| 1.22. | White biotechnology global capacity forecast 2024-2034 |
| 1.23. | White biotechnology global capacity forecast 2024-2034: discussion |
| 1.24. | Emerging areas of white biotechnology forecast 2024-2034 |
| 1.25. | Company profiles |
| 2. | INTRODUCTION |
| 2.1. | Glossary of acronyms |
| 2.2. | Glossary of terms |
| 2.3. | Colors of biotechnology |
| 2.4. | What is white biotechnology? |
| 2.5. | The bioeconomy and white biotechnology |
| 2.6. | Report focus |
| 3. | MARKET ANALYSIS |
| 3.1. | Market Drivers for White Biotechnology |
| 3.1.1. | Market drivers: demand for biobased products |
| 3.1.2. | Market drivers: government regulation on petroleum-based plastic use |
| 3.1.3. | Market drivers: government support of biotechnology |
| 3.1.4. | Market drivers: carbon taxes |
| 3.2. | Economic Viability of White Biotechnology |
| 3.2.1. | Factors affecting the economic viability of white biotechnology projects |
| 3.2.2. | Effects of Brent crude prices on biobased products |
| 3.2.3. | The Green Premium |
| 3.2.4. | Rising feedstock prices |
| 3.2.5. | Effect of cell factory on cost |
| 3.2.6. | Identifying the chemicals with the most potential to become biobased based on price |
| 3.2.7. | How scale-up affects cost |
| 3.2.8. | Zymergen: case study on economics of synthetic biology |
| 3.2.9. | Synthetic biology: shift from commodity products to lower volume, high value markets |
| 3.2.10. | Major market challenges for white biotechnology |
| 3.3. | Player and Start-up Landscape |
| 3.3.1. | Players: synthetic biology tools and platforms |
| 3.3.2. | Players: vertically integrated biomanufacturing |
| 3.3.3. | Emerging players segmented by molecule |
| 3.3.4. | Overview of chemicals and materials companies involved in white biotechnology |
| 4. | CELL FACTORIES FOR WHITE BIOTECHNOLOGY |
| 4.1. | Cell factories for biomanufacturing: factors to consider |
| 4.2. | Cell factories for biomanufacturing: a range of organisms |
| 4.3. | Escherichia coli (E.coli) |
| 4.4. | Corynebacterium glutamicum (C. glutamicum) |
| 4.5. | Bacillus subtilis (B. subtilis) |
| 4.6. | Saccharomyces cerevisiae (S. cerevisiae) |
| 4.7. | Yarrowia lipolytica (Y. lipolytica) |
| 4.8. | Microorganisms used in different biomanufacturing processes |
| 4.9. | Non-model organisms for white biotechnology |
| 5. | TECHNOLOGY DEVELOPMENTS |
| 5.1. | Synthetic Biology |
| 5.1.1. | Synthetic biology: the design and engineering of biological systems |
| 5.1.2. | Synthetic biology: manipulating the central dogma |
| 5.1.3. | The vast scope of synthetic biology |
| 5.1.4. | The Process of Synthetic Biology: Design, Build and Test |
| 5.1.5. | Synthetic biology: why now? |
| 5.1.6. | Synthetic biology: from pharmaceuticals to consumer products |
| 5.1.7. | Synthetic biology: disrupting existing supply chains |
| 5.1.8. | Synthetic biology: drivers and barriers for adoption |
| 5.1.9. | Synthetic biology as applied to white biotechnology |
| 5.2. | Tools and Techniques of Synthetic Biology |
| 5.2.1. | Tools and techniques of synthetic biology: overview |
| 5.2.2. | DNA Synthesis |
| 5.2.3. | Introduction to CRISPR-Cas9 |
| 5.2.4. | CRISPR-Cas9: a bacterial immune system |
| 5.2.5. | CRISPR-Cas9's importance to synthetic biology |
| 5.2.6. | Protein/Enzyme Engineering |
| 5.2.7. | Computer-Aided Design |
| 5.2.8. | Commercial examples of engineered proteins in industrial applications |
| 5.2.9. | Strain construction and optimization |
| 5.2.10. | Synergy between synthetic biology and metabolic engineering |
| 5.2.11. | Framework for developing industrial microbial strains |
| 5.2.12. | The problem with scale |
| 5.2.13. | Introduction to cell-free systems |
| 5.2.14. | Cell-free versus cell-based systems |
| 5.2.15. | Cell-free systems in the context of white biotechnology |
| 5.2.16. | Cell-free systems for white biotechnology |
| 5.2.17. | Commercial implementation of cell-free systems: Solugen |
| 5.2.18. | Startups pursuing cell-free systems for white biotechnology |
| 5.2.19. | Robotics: enabling hands-free and high throughput science |
| 5.2.20. | Robotic cloud laboratories |
| 5.2.21. | Automating organism design and closing the loop |
| 5.2.22. | Artificial intelligence and machine learning |
| 5.3. | Improvement of Biomanufacturing Processes |
| 5.3.1. | Continuous vs batch biomanufacturing |
| 5.3.2. | Benefits and challenges of continuous biomanufacturing |
| 5.3.3. | Continuous vs batch biomanufacturing: key fermentation parameter comparison |
| 5.3.4. | Machine learning to improve biomanufacturing processes |
| 5.4. | White Biotechnology for Sustainability |
| 5.4.1. | White biotechnology as a sustainable technology |
| 5.4.2. | Routes for carbon capture in white biotechnology |
| 5.4.3. | Autotrophic bacteria for carbon capture through biomanufacturing |
| 5.5. | Alternative Feedstocks for Biomanufacturing |
| 5.5.1. | Why use alternative feedstocks for white biotechnology? |
| 5.5.2. | Food, land, and water competition |
| 5.5.3. | C1 feedstocks: metabolic pathways |
| 5.5.4. | C1 feedstocks: economic benefits |
| 5.5.5. | C1 feedstocks: challenges |
| 5.5.6. | Non-methane C1 feedstocks |
| 5.5.7. | C1 feedstocks: products |
| 5.5.8. | C1 feedstocks: gas fermentation |
| 5.5.9. | C2 feedstocks |
| 5.5.10. | C2 feedstocks: products segmented by feedstock |
| 5.5.11. | C1 and C2 feedstocks: commercial activity |
| 5.5.12. | C1 and C2 feedstocks: commercial activity |
| 5.5.13. | Lignocellulosic biomass feedstocks |
| 5.5.14. | Lignocellulosic biomass feedstocks: challenges |
| 5.5.15. | Lignocellulosic biomass feedstocks: products |
| 5.5.16. | Lignocellulosic feedstocks: commercial activity |
| 6. | BLUE BIOTECHNOLOGY |
| 6.1. | What is blue biotechnology? |
| 6.2. | Main biocatalysts of blue biotechnology: cyanobacteria and algae |
| 6.3. | Cyanobacteria |
| 6.4. | Algae |
| 6.5. | Key drivers and challenges for blue biotechnology |
| 6.6. | Selected startups in blue biotechnology |
| 7. | PRODUCTS DERIVED FROM WHITE BIOTECHNOLOGY |
| 7.1. | Overview |
| 7.1.1. | Products derived from white biotechnology: overview |
| 7.2. | Fuels |
| 7.2.1. | Biofuels made from white biotechnology |
| 7.2.2. | Metabolic pathways to biofuels |
| 7.2.3. | Bioethanol |
| 7.2.4. | Next-generation bioethanol |
| 7.2.5. | Next-generation ethanol - operational plants |
| 7.2.6. | Next-generation ethanol - operational plants |
| 7.2.7. | Next-generation ethanol - planned plants |
| 7.2.8. | Next-generation ethanol - non-operational and cancelled plants |
| 7.2.9. | Diesel from biomanufacturing pathways |
| 7.2.10. | Farnesene |
| 7.2.11. | n-Butanol |
| 7.2.12. | Isobutanol |
| 7.2.13. | Methanol |
| 7.2.14. | Blue biotechnology in biofuel production |
| 7.2.15. | Blue biotechnology in biodiesel production |
| 7.2.16. | Blue biotechnology in bioethanol production |
| 7.2.17. | Blue biotechnology for biofuel production: key challenges for commercial viability |
| 7.2.18. | Blue biotechnology for biofuel production: commercial activity by US oil producers |
| 7.2.19. | Blue biotechnology for biofuel production: commercial activity by non-US oil producers |
| 7.2.20. | Blue biotechnology for biofuel production: list of current and former players |
| 7.2.21. | Blue biotechnology for biofuel production: list of current and former players |
| 7.2.22. | Blue biotechnology for biofuel production: list of current and former players |
| 7.3. | Plastics and Textiles |
| 7.3.1. | Introduction to bioplastics |
| 7.3.2. | Production of bioplastics through white biotechnology |
| 7.3.3. | Navigating biobased polymers from monosaccharides |
| 7.3.4. | Common bioplastics and bioplastic precursors synthesized via white biotechnology |
| 7.3.5. | Lactic Acid and Polylactic Acid (PLA) |
| 7.3.6. | Molecules for Other Biobased Synthetic Polyesters |
| 7.3.7. | Molecules for Other Biobased Synthetic Polymers |
| 7.3.8. | Naturally Occurring Biobased Polymers: Polyhydroxyalkanoates (PHAs) |
| 7.3.9. | Other Textiles Produced through White Biotechnology |
| 7.4. | Other Chemicals, Precursors, and Additives |
| 7.4.1. | Acetone |
| 7.4.2. | Acrylic acid |
| 7.4.3. | Itaconic acid |
| 7.4.4. | Biobased ethanol as a precursor |
| 7.4.5. | Biomanufacturing of ethylene |
| 7.4.6. | Monoethylene glycol (MEG) |
| 7.4.7. | Biobased MEG: monomer production |
| 7.4.8. | Biobased MEG: industry landscape |
| 7.4.9. | Polyethylene terephthalate (PET) |
| 7.4.10. | Biobased polyolefins |
| 7.4.11. | Braskem: "I'm green" polyethylene |
| 7.4.12. | Biomanufacturing of propylene precursors |
| 7.4.13. | Malonic acid |
| 7.4.14. | Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs) |
| 7.4.15. | Short chain fatty acids: acetic acid |
| 7.4.16. | Triglycerides |
| 7.4.17. | Other organic acids and aldehydes |
| 7.4.18. | Bacterial cellulose |
| 7.5. | Other Products Derived from White Biotechnology |
| 7.5.1. | Overview of vitamins and amino acids produced through white biotechnology |
| 7.5.2. | Overview of white biotechnology for cosmetics |
| 7.5.3. | Biomanufacturing for surfactants and detergents |
| 7.5.4. | Enzymes for onward use: Novozymes |
| 7.5.5. | Cement alternatives from biomanufacturing: BioMason |
| 7.5.6. | Precision fermentation: definition and scope |
| 8. | FORECASTS FOR WHITE BIOTECHNOLOGY |
| 8.1. | Forecast methodology |
| 8.2. | White biotechnology market share by molecule 2024-2034 |
| 8.3. | White biotechnology global capacity forecast 2024-2034 |
| 8.4. | White biotechnology global capacity forecast 2024-2034: discussion |
| 8.5. | White biotechnology global capacity forecast 2024-2034: discussion |
| 8.6. | Emerging areas of white biotechnology forecast 2024-2034 |
| 8.7. | Emerging areas of white biotechnology forecast: discussion |
| 9. | COMPANY PROFILES |
| 9.1. | Arzeda |
| 9.2. | Bolt Threads |
| 9.3. | CinderBio |
| 9.4. | Danimer Scientific |
| 9.5. | Ecovative |
| 9.6. | Kraig Biocraft Laboratories |
| 9.7. | LanzaTech |
| 9.8. | Mango Materials |
| 9.9. | Metabolic Explorer |
| 9.10. | Modern Meadow |
| 9.11. | Natureworks |
| 9.12. | Newlight Technologies |
| 9.13. | Novozymes |
| 9.14. | Spiber |
| 9.15. | Succinity |
| 9.16. | Total Corbion |
| 10. | APPENDIX |
| 10.1. | White biotechnology global capacity forecast 2024-2034 |
| 10.2. | Emerging areas of white biotechnology forecast 2024-2034 |